<DOC>
	<DOCNO>NCT02060032</DOCNO>
	<brief_summary>Background : Statins recently evolve agent aid periodontal regeneration ultimately attain periodontal health . Atorvastatin ( ATV ) Simvastatin ( SMV ) specific competitive inhibitor 3-hydroxy-2-methyl-glutaryl coenzyme A reductase . The present study design evaluate compare effectiveness 1.2 % ATV , 1.2 % SMV adjunct scale root planing ( SRP ) treatment subject chronic periodontitis . Methods : Ninety six subject categorize three treatment group : SRP plus 1.2 % ATV , SRP plus 1.2 % SMV SRP plus placebo . Clinical parameter ; full mouth plaque index ( PI ) , modify sulcus bleed index ( mSBI ) , probe depth ( PD ) , relative attachment level ( RAL ) record baseline SRP 3 , 6 9 month . Percentage radiographic defect depth reduction evaluate use computer-aided software baseline , 6 month 9 month .</brief_summary>
	<brief_title>1.2 % Atorvastatin 1.2 % Simvastatin Treatment Chronic Periodontitis</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Moderate severe CP subject PD ≥ 5 mm clinical attachment level ( CAL ) ≥ 4 mm vertical bone loss ≥3 mm intraoral periapical radiograph history antibiotic periodontal therapy precede 6 month Individuals systemic disease know alter course periodontal disease treatment outcome , know suspect allergy SMV/ATV/statin group , systemic SMV/ATV/statin therapy , individual aggressive periodontitis , use tobacco form , alcoholic , individual diabetes , immunocompromised individual , pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Chronic periodontitis , Local drug delivery ,</keyword>
</DOC>